Equity Overview
Price & Market Data
Price: $0.15
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $477,852
Daily Volume: 0
Performance Metrics
1 Week: -31.82%
1 Month: -78.57%
3 Months: -80.52%
6 Months: -72.73%
1 Year: -88.97%
YTD: -80.00%
Company Details
Employees: 2
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. The company product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; and intravenous tramadol for the treatment of post-operative acute pain. It also develops BAER-101 for the treatment of epilepsy and panic disorders. The company was incorporated in 2015 and is headquartered in Bay Harbor Islands, Florida. Avenue Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.